Erythromycin thiocyanate is a macrolide antibiotic classified as Biopharmaceutical Classification System (BCS) class II, characterized by low solubility (±2 mg/mL) and oral bioavailability of approximately 17%. This study aimed to optimize a liquid self-nanoemulsifying drug delivery system (L-SNEDDS) and develop it into a solid SNEDDS (S-SNEDDS) to enhance the dissolution of erythromycin thioc…